首页> 外文期刊>Diagnostic microbiology and infectious disease >Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay.
【24h】

Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay.

机译:检测肺炎支原体,肺炎衣原体和军团菌。在临床标本中使用单管多重实时PCR分析。

获取原文
获取原文并翻译 | 示例
           

摘要

A multiplex real-time PCR assay for the detection of Mycoplasma pneumoniae (MP181), Chlamydia (Chlamydophila) pneumoniae (CP-Arg), Legionella spp. (Pan-Leg), and the human RNase P (RNase P) gene was developed for rapid testing of atypical bacterial respiratory pathogens in clinical specimens. This method uses 4 distinct hydrolysis probes to detect 3 leading causes of community-acquired pneumonia. The assay was evaluated for specificity and sensitivity by testing against 35 related organisms, a dilution series of each specific target and 197 clinical specimens. Specificity testing demonstrated no cross-reactivity. A comparison to previously validated singleplex real-time PCR assays for each agent was also performed. The analytical sensitivity for specific pathogen targets in both the singleplex and multiplex was identical (50 fg), while efficiencies ranged from 82% to 97% for the singleplex assays and from 90% to 100% for the multiplex assay. The clinical sensitivity of the multiplex assay was improved for the Pan-Leg and CP-Arg targets when compared to the singleplex. The MP181 assay displayed equivalent performance. This multiplex assay provides an overall improvement in the diagnostic capability for these agents by demonstrating a sensitive, high-throughput and rapid method. This procedure may allow for a practical and efficient means to test respiratory clinical specimens for atypical pneumonia agents in health care settings and facilitate an appropriate public health response to outbreaks.
机译:用于检测肺炎支原体(MP181),肺炎衣原体(衣原体),肺炎衣原体(CP-Arg),军团菌属菌种的多重实时PCR检测方法。 (Pan-Leg)和人类RNase P(RNase P)基因被开发用于快速检测临床标本中的非典型细菌呼吸道病原体。该方法使用4种不同的水解探针来检测3种导致社区获得性肺炎的主要原因。通过针对35个相关生物,每个特定靶标的稀释系列和197个临床样本进行测试,评估了该方法的特异性和敏感性。特异性测试表明没有交叉反应。还对每种试剂与先前验证的单重实时PCR分析进行了比较。单重和多重分析中对特定病原体靶标的分析灵敏度相同(50 fg),而单重分析的效率为82%至97%,多重分析的效率为90%至100%。与单重体相比,针对Pan-Leg和CP-Arg靶标的多重分析的临床敏感性得到了提高。 MP181测定显示出相同的性能。通过证明一种灵敏,高通量和快速的方法,该多重测定法对这些药物的诊断能力提供了全面的改进。该程序可以提供一种实用有效的手段,以在卫生保健机构中测试呼吸道临床样本中的非典型肺炎药,并促进对疾病爆发的适当公共卫生响应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号